Pharmacology, Toxicology and Pharmaceutical Science
Prodrug
100%
HIV
73%
Dolutegravir
60%
Pharmacokinetics
58%
Mouse
40%
Cabotegravir
37%
Nanoparticle
36%
Biodistribution
31%
Infection
29%
Rilpivirine
23%
Viral Clearance
20%
Atazanavir
18%
Lamivudine
18%
Poloxamer
17%
Rhesus Monkey
17%
Abacavir
17%
Matrix Metalloproteinase
15%
Nanocarrier
15%
Hepatitis B Virus
15%
Antivirus Agent
14%
Elimination
13%
Drug Concentration
13%
Folic Acid
13%
Integrase
12%
Drug Formulation
12%
Adverse Event
12%
Drug Release
11%
Sustained Release
10%
Intramuscular Injection
9%
Integrase Inhibitor
9%
Formulation Design
8%
Europium
8%
Emtricitabine
8%
Human Immunodeficiency Virus 1
8%
Neurologic Disease
7%
Mannose
7%
Heptapeptide
7%
Human Immunodeficiency Virus 1 Infection
7%
Mouse Model
7%
Amphotericin B
7%
Darunavir
7%
Neutralizing Antibody
7%
Ritonavir
7%
Efavirenz
7%
Drug Delivery System
7%
Magnetite Nanoparticle
7%
Ryanodine Receptor 2
7%
Drug Carrier
7%
Chemokine Receptor
7%
SARS Coronavirus
7%
Keyphrases
Prodrug
37%
Cabotegravir
22%
ProTide
22%
Nanocrystals
21%
Antiretroviral Therapy
20%
Human Immunodeficiency Virus Type 1 (HIV-1)
18%
Pharmacokinetic Profile
17%
Long-acting Antiretrovirals
15%
Ultra-long
15%
Dolutegravir
15%
Lipophilic
14%
Antiretroviral
11%
Long-acting Parenteral
9%
Virus
9%
Humanized Mice
8%
Latent Viral Reservoir
7%
Drug Nanocrystals
7%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
7%
Long-acting Drug Delivery Systems
7%
Darunavir
7%
Triphosphate
7%
Neurotheranostics
7%
Viral Disease
7%
HBV Replication
7%
Prodrug Therapy
7%
Fragment Condensation
7%
Rhesus Macaque
7%
D-Ser
7%
Multimodal Theranostics
7%
Lamivudine
7%
Pharmacokinetic Evaluation
7%
Core-shell Silica
7%
CRISPR Editing
7%
Europium
7%
Cobalt Ferrite
7%
Folate Receptor
7%
Tenofovir
7%
Drug Entry
7%
Rilpivirine
7%
Depot
6%
Pharmacokinetics
6%
Thiolated chitosan
6%
Monocyte-derived Macrophages
6%
Pronucleotides
6%
Theranostic Probe
5%
Bismuth Sulfide
5%
Theranostic Nanoparticles
5%
Antiviral Drugs
5%
Targeting Ligands
5%
Therapeutic Agents
5%